BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Janssen EM, Dy SM, Meara AS, Kneuertz PJ, Presley CJ, Bridges JFP. Analysis of Patient Preferences in Lung Cancer - Estimating Acceptable Tradeoffs Between Treatment Benefit and Side Effects. Patient Prefer Adherence 2020;14:927-37. [PMID: 32581519 DOI: 10.2147/PPA.S235430] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Viswanath D, Won YY. Combining Radiotherapy (RT) and Photodynamic Therapy (PDT): Clinical Studies on Conventional RT-PDT Approaches and Novel Nanoparticle-Based RT-PDT Approaches under Preclinical Evaluation. ACS Biomater Sci Eng 2022. [PMID: 36000986 DOI: 10.1021/acsbiomaterials.2c00287] [Reference Citation Analysis]
2 Pribish AM, Secemsky EA, Schmaier AA. Venous Thromboembolism for the Practicing Cardiologist. Cardiol Clin 2021;39:551-66. [PMID: 34686267 DOI: 10.1016/j.ccl.2021.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Bever A, Manthorne J, Rahim T, Moumin L, Szabo SM. The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer. Patient 2021. [PMID: 34643935 DOI: 10.1007/s40271-021-00552-w] [Reference Citation Analysis]
4 Bousema JE, Hoeijmakers F, Dijkgraaf MGW, Annema JT, van den Broek FJC, van den Akker-van Marle ME; MEDIASTrial Study Group. Patients' Preferences Regarding Invasive Mediastinal Nodal Staging of Resectable Lung Cancer. Patient Prefer Adherence 2021;15:2185-96. [PMID: 34588768 DOI: 10.2147/PPA.S319790] [Cited by in F6Publishing: 1] [Reference Citation Analysis]